Pharmacokinetics of a Single Dose of Azilsartan in Pediatric Patients: A Phase 3, Open-Label, Multicenter Study

被引：0

作者：

Kazuaki Enya

Ben T. Saji

Takuya Kato

Hiroyuki Okamoto

Emiko Koumura

机构：

[1] Takeda Pharmaceutical Co. Ltd,Japan Development Center

[2] Toho University Omori Medical Center,First Department of Pediatrics

[3] Takeda Pharmaceutical Co. Ltd,Formerly Japan Development Center

来源：

Advances in Therapy | 2018年 / 35卷

关键词：

Angiotensin II receptor blocker; Azilsartan; Cardiology; Hypertension; Pediatric; Pharmacokinetics;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1181 / 1190

页数：9

共 50 条

[41] Efficacy and safety of lanadelumab in Japanese patients with hereditary angioedema: A phase 3 multicenter, open-label study
Hide, Michihiro
Ohsawa, Isao
Nurse, Christina
Yu, Ming
JOURNAL OF DERMATOLOGY, 2023, 50 (11): : 1381 - 1391
[42] Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia
O'Brien, Maureen M.
Alonzo, Todd A.
Cooper, Todd M.
Levine, John E.
Brown, Patrick A.
Slone, Tamra
August, Keith J.
Benettaib, Bouchra
Biserna, Noha
Poon, Jennifer
Patturajan, Meera
Chen, Nianhang
Simcock, Mathew
Zimmerman, Linda
Kolb, E. Anders
PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
[43] Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate 3-Month Formulation in Patients With Schizophrenia: A Phase-I, Single-Dose, Randomized, Open-Label Study
Ravenstijn, Paulien
Remmerie, Bart
Savitz, Adam
Samtani, Mahesh N.
Nuamah, Isaac
Chang, Cheng-Tao
De Meulder, Marc
Hough, David
Gopal, Srihari
JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (03): : 330 - 339
[44] Efficacy and safety of tolvaptan in patients with malignant ascites: a phase 2, multicenter, open-label, dose-escalation study
Kudo, Toshihiro
Murai, Yoshiyuki
Kojima, Yoshitsugu
Uehara, Kenji
Satoh, Taroh
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 354 - 362
[45] Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumors
Minami, Hironobu
Ando, Yuichi
Ma, Brigette Buig Yue
Lee, Jih-Hsiang
Momota, Hiroyuki
Fujiwara, Yutaka
Li, Leung
Fukino, Koichi
Ito, Koji
Tajima, Takeshi
Mori, Asuka
Lin, Chia-Chi
CANCER SCIENCE, 2016, 107 (10) : 1477 - 1483
[46] A Phase 1, open-label, crossover study evaluating the effect of a single dose of sodium zirconium cyclosilicate on the pharmacokinetics of tacrolimus and cyclosporin
Nagard, Mats
Choudhury, Nurul
Lisovskaja, Vera
Mackillop, Neil
Al-Shurbaji, Ayman
CLINICAL KIDNEY JOURNAL, 2023, 16 (01) : 151 - 158
[47] Pharmacokinetics and tolerability of sublingual fentanyl in healthy Japanese and Caucasian volunteers: Phase I, open-label single-dose study
Lorch, U.
Farrell, F.
Kilborn, J.
Tarnaoka, M.
Derrick, R.
Howell, J.
PROCEEDINGS OF THE 13TH INTERNATIONAL PAIN CLINIC CONGRESS: WORLD SOCIETY OF PAIN CLINICIANS, 2008, : 131 - +
[48] A PHASE 1, OPEN-LABEL, CROSSOVER STUDY EVALUATING THE EFFECT OF A SINGLE DOSE OF SODIUM ZIRCONIUM CYCLOSILICATE ON THE PHARMACOKINETICS OF TACROLIMUS AND CYCLOSPORIN
Nagard, Mats
Choudhury, Nurul
Lisovskaja, Vera
Mackillop, Neil
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I135 - I136
[49] A Phase-I, Open-Label, Single-Dose Study of the Pharmacokinetics of Buparlisib in Subjects With Mild to Severe Hepatic Impairment
Csonka, Denes
Hazel, Katharine
Waldron, Edward
Lorenzo, Sebastien
Duval, Vincent
Trandafir, Lucia
Kobalava, Zhanna D.
JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (03): : 316 - 323
[50] Pharmacokinetics of capmatinib in participants with hepatic impairment: A phase 1, open-label, single-dose, parallel-group study
Chen, Xinhui
Cui, Xiaoming
Pognan, Nathalie
Quinlan, Michelle
Kapoor, Shruti
Rahmanzadeh, Gholamreza
Giovannini, Monica
Marbury, Thomas C.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 91 - 102

← 1 2 3 4 5 →